« Back to the previous page

Generic drugs manufacturer

First generic manufacturer to buy

• Revenue of the firm to be acquired should be between €5m - €10m
• An European pharmaceutical firm is being sought to be acquired
• #CFIE SYI 007
• Reason for acquisition: This multinational corporation wants to expand its operations into European markets. The acquirer is looking to buy a manufacturer of first generic drugs in Europe.

First generic drugs manufacturer buyer

A China based pharmaceutical and biotechnology firm is interested to acquiring a first generic manufacturer based in Europe. This acquisition is in order to expand the operations of this Asian multinational corporation from Asia into Europe. Revenues of the firm to be acquired should be within €5m - €10m. The pharmaceutical and biotechnology firm has holdings in many other sectors and has ample resources for expansion. The company manufactures pharmaceutical products in China and is also very heavily active in research and development. The firm’s product range includes cardio-cerebrovascular drugs, pediatric drug, anti-infective drugs and rehabilitation drugs. The first generic drugs manufacturer has state of the art research and development facilities that re up to GMP standards. The acquirer is listed on a major Chinese exchange and therefore adheres to the stringent corporate rules and regulations of that exchange. The first generic manufacturer to be acquired should be in good financial standing and have domestic growth opportunities to be capitalised on by the acquirer.

First generic manufacturer wanted

The buyer is looking for a first generic manufacturer with all licenses and patents based within Europe. The buyer is looking to expand into the European market. The company to be bought must have all necessary licenses and patents and maintain the highest of quality standards.

First generic drugs manufacturer to buy

The pharmaceutical and biotechnology manufacturer adheres to the highest of global quality standards and is looking for first generic manufacturer in Europe that also follows stringent quality guidelines. The buyer is looking for a first generic drugs manufacturer that possess all necessary licenses and patents and that manufactures drugs that are exactly the same as brand drugs in the following aspects:

• Quality
• Safety
• Dosage
• Strength
• The way it is taken
• The way it works

Highlights of first generic drugs manufacturer

• The target company should be a first generic drugs manufacturer based in Europe.
• The buyer is a multinational investment holding company heavily active in the pharmaceutical and biotechnology industry
• Acquirer has a global business network that spans 5 continents
• The buyer has ample resources for expansion post acquisition

Information on this tablet and capsule manufacturer wanted

Please do not hesitate to contact us should you know of a first generic drugs manufacturer that may be interested in being acquired. This buyer aims to acquire an European operating company that possess license and patents for its product lines . For pharmaceutical companies for sale please visit the section pharma companies for sale. For pharmaceutical buyers please visit the section pharma companies wanted. For an overview of our pharma M&A team please visit pharma M&A team.